1993
DOI: 10.1254/jjp.62.67
|View full text |Cite
|
Sign up to set email alerts
|

Human Aortic Smooth Muscle Cells Containing Angiotensin II Type 1 Receptors

Abstract: ABSTRACT-The mechanism of pindolol-induced vasoconstriction in isolated and perfused dog coronary arteries was studied. Single injections of pindolol (1-100 ,ug), propranolol (1-30 pg), and 5-hydroxytryp tamine (5-HT, 0.001-1 ,ug) produced a dose-related vasoconstriction in dog coronary arteries which were dilated by acetylcholine. 1-Pindolol constricted coronary arteries, but d-pindolol did not. The responses to pindolol and propranolol were not affected by any of the following compounds (100 rig): bunazosin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1996
1996
1998
1998

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…P-Adrenoceptor blocking agents such as pindolol and propranolol are widely used as 5-HTlA and 5-HTIB receptor antagonists in in vitro vessel studies. However, pindolol and propranolol have also been demonstrated to cause vasoconstrictions through activation of 5-HT,-like receptors (Nakane et al, 1993). In addition, pindolol and propranolol have been shown to behave as partial or full agonists at the 5-HTlB receptors (Unsworth & Molinoff, 1992;Adham et al, 1993), and to behave as partial agonists at 5-HTID receptors (Schoeffter & Hoyer, 1989b).…”
Section: Discussionmentioning
confidence: 99%
“…P-Adrenoceptor blocking agents such as pindolol and propranolol are widely used as 5-HTlA and 5-HTIB receptor antagonists in in vitro vessel studies. However, pindolol and propranolol have also been demonstrated to cause vasoconstrictions through activation of 5-HT,-like receptors (Nakane et al, 1993). In addition, pindolol and propranolol have been shown to behave as partial or full agonists at the 5-HTlB receptors (Unsworth & Molinoff, 1992;Adham et al, 1993), and to behave as partial agonists at 5-HTID receptors (Schoeffter & Hoyer, 1989b).…”
Section: Discussionmentioning
confidence: 99%